Skip to main content
. 2023 Jul 13;14:1235285. doi: 10.3389/fphar.2023.1235285

FIGURE 2.

FIGURE 2

The effect of MK-2206 on the efficacy of mitoxantrone, SN-38 and topotecan in the ABCG2-overexpressing cancer cell lines, H460/MX20 (A, B, C) and S1-M1-80 (D, E, F). Each point in the graphs represents the % mean cell viability ± SD (n = 3).